Updated recommendation on cancer screening is based on the latest scientific advice. The new guidance updates the 2003 Council Recommendation and is one of the flagship elements of the Europe’s Beating Cancer P […]

UPDATE on DESTINY-Gastric02 Study: Trastuzumab Deruxtecan Continues to Demonstrate Benefit in Metastatic Gastric and Gastro-oesophageal Cancer

Earlier this month the Czech Presidency of the EU conducted an informal meeting of EU health ministers in Prague. Ministers discussed oncology, rare diseases, vaccination (where presidency is expected to present […]

DiCE was invited to participate in the symposium organised by the gastroenterology and gastrointestinal Endoscopy Unit from the San Raffaele Scientific Institute in Milan to update the 28 statements for the […]

Digestive Cancers Europe (DiCE) and European Liver Patients’ Association (ELPA) will host a European policy event on 12 October 2022 at the European Parliament.
Bringing together experts, policymakers, pat […]

Calling All Full Members! Applications are now Open for the Wolfram Nolte Memorial Award for Colorectal Cancer Projects

The European Patients’ Forum (EPF) conducted a COVID-19 survey between 18 September to 18 October 2020 (the report is available here).  It aimed to gather more information on the lived experience and impact of t […]

The Use of Circulating Tumor DNA Assays – Clinical Recommendations from ESMO for Patients with Cancer

Over the past decade liquid biopsies have emerged as a powerful tool to assess new biomarkers for p […]

This autumn, the European institutions will be discussing how our health data should be processed, stored and shared as a part of the European Health Data Space (EHDS). Along with other European health […]

In June the European Commission has produced a guiding document “Healthier Together: EU Non-Communicable Diseases (NCDs) Initiative”. The initiative was launched in December 2021 and is being run from 202 […]

An international consortium of researchers conducted a trial to assess whether a ctDNA-guided approach could reduce the use of adjuvant chemotherapy in a patient with stage II colon cancer without compromising […]

Scientists at the Institute of research in Barcelona (Spain) identified a cell population responsible for the recurrence of colon cancer after chemotherapy. The researchers have discovered the mechanism through […]

Following a series of regional round-tables to gain better understanding of the departmental and regional differences of treating pancreatic patients in France, our Member A.R.CA.D has launched a call for […]